Atlas Trials

Staccato Prochlorperazine Thorough QT/QTc

Clinical trial NCT00543062 · COMPLETED

Trial details

NCT number
NCT00543062
Sponsor
Alexza Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cardiotoxicity
Start date
2007-10-01
Primary completion
2007-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.